1.Paje, D, Conlon, A, Kaatz, S, et al.Patterns and predictors of short-term peripherally inserted central catheter use: a multicenter prospective cohort study. J Hosp Med 2018;13:76–82.
2.Chopra, V, Anand, S, Hickner, A, et al.Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet 2013;382:311–325.
3.Chopra, V, O’Horo, JC, Rogers, MA, Maki, DG, Safdar, N. The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 2013;34:908–918.
4.Xu, T, Kingsley, L, DiNucci, S, et al.Safety and utilization of a peripherally inserted central catheters versus midline catheters at a large academic medical center. Am J Infect Control 2016;44:1458–1461.
5.Mushtaq, A, Navalkele, B, Kaur, M, et al.Comparison of complications in midlines versus central venous catheters: are midlines safer than central venous lines? Am J Infect Control 2018;46:788–792.
6.Cawcutt, KA, Hankins, RJ, Micheels, TA, Rupp, ME. Optimizing vascular-access device decision-making in the era of midline catheters. Infect Control Hosp Epidemiol 2019;40:674–680.
7.Chopra, V, Kaatz, S, Swaminathan, L, et al.Variation in use and outcomes related to midline catheters: results from a multicenter pilot study. BMJ Qual Safety 2019;28:714–720.
8.Krein, SL, Saint, S, Trautner, BW, et al.Patient-reported complications related to peripherally inserted central catheters: a multicenter prospective cohort study. BMJ Qual Safety 2019;28:574–581.
9.Chopra, V, Saint, S, Woller, SC, et al.The Michigan appropriateness guide for intravenous catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method. Ann Intern Med 2015;163 suppl 6:S1–S40.
10.DeVries, M, Lee, J, Hoffman, L, Infection free midline catheter implementation at a community hospital (2 years). Am J Infect Control 2019;47:1118–1121.